Clinical trial · Interventional
Meru Health Program for Cancer Patients With Depression and Anxiety
Feasibility of a Therapist-Supported Digital Mental Health Intervention in Addressing Mental Health Symptoms Among People With Cancer: A Mixed Methods Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The primary objective of this study is to evaluate clinical outcomes among people with cancer who participate in a 12-week therapist-supported digital mental health intervention (DMHI) called the Meru Health Program (MHP). Study participants (N=20) will be referred to the MHP through the Cancer Support Community (CSC) Helpline and network of Gilda's Club locations. The main outcomes will be depression symptoms, anxiety symptoms, health-related quality of life (HRQoL), intervention adherence, and intervention satisfaction. The secondary objective will be to determine the acceptability of the screening and referral process from the CSC networks into the MHP. Data pertaining to implementability will be collected from study participants, MHP clinicians, and CSC staff.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Anxiety | — | UNRESOLVED | — |
| Depression | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Meru Health Program | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Treatment Group
- description
- This single-arm study will enroll all 20 participants in the Meru Health Program.
- interventionNames
- Behavioral: Meru Health Program
Primary outcomes (4)
- measure
- Change in PHQ-9 Scores
- timeFrame
- Baseline, Week 12, and 2 Month Follow-Up time points
- description
- 9-item questionnaire to measure depression symptoms
- measure
- Change in GAD-7 Scores
- timeFrame
- Baseline, Week 12, and 2 Month Follow-Up time points
- description
- 7-item questionnaire to measure anxiety symptoms
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Positive screen (score \>= 3 out of 8) on the anxiety or depression subscale of the CSS 15+ Questionnaire * PHQ-9 and/or GAD-7 score \>= 5 at clinical intake * Willing to commit to the Meru Health Program if selected * Proficient in the English language * At least 18 years of age at the time of enrollment * Has a valid mailing address * Owns 1 of the 3 past versions of an Apple or Android mobile phone operating system * Currently in active cancer treatment at the time of enrollment Exclusion Criteria: * Active suicide intent with plan to act * Substance use disorder in the past 3 months * Lifetime bipolar disorder * Lifetime psychotic disorder * Currently pregnant * Less than 3 months postpartum
References
Publications (0)
Data not yet available